; (vii) the Department of Veterans Affairs; (viii) the Food and Drug Administration; (ix) the Department of Defense; (x) the Environmental Protection Agency; (xi) the Office of Minority Health; (xii) the Indian Health Service; and (xiii) other relevant Federal departments and agencies as determined by the Secretary. (B) Non-Federal members In addition to the members listed in subparagraph (A), the Advisory Council shall include 10 expert members from outside the Federal Government, to be appointed by the Secretary, which members shall include— (i) 2 Parkinson’s patient advocates, at least 1 of whom is living with young-onset Parkinson’s; (ii) 1 Parkinson’s family caregiver; (iii) 1 health care provider; (iv) 2 biomedical researchers with Parkinson’s-related expertise in basic, translational, clinical, or drug development science; (v) 1 movement disorder specialist who treats Parkinson’s patients; (vi) 1 dementia specialist who treats Parkinson’s patients; and (vii) 2 representatives from nonprofit organizations that have demonstrated experience in Parkinson’s research or Parkinson’s patient care and other services. (3) Meetings (A) Quarterly meetings The Advisory Council shall meet at least once each quarter. (B) Biannual research meeting Not later than 24 months after the date of enactment of this Act, and every 2 years thereafter, the Advisory Council shall convene a meeting of Federal and non-Federal organizations to discuss Parkinson’s research. (C) Open meetings The meetings of the Advisory Council shall be open to the public. (4) Advice The Advisory Council shall advise the Secretary on Parkinson’s-related issues. (5) Biannual report Not later than 18 months after the date of enactment of this Act, and every 2 years thereafter, the Advisory Council shall provide to the Secretary and Congress a report containing— (A) an evaluation of all federally funded efforts in Parkinson’s research, prevention, clinical care, and institutional-, home-, and community-based programs and the outcomes of such efforts